Newsletters - JAN-FEB 2006

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Sabinsa Corporation's Ò was named as the curcumin ingredient of choice by M.D. Anderson Cancer Center at the University of Texas. M.D. Anderson Cancer Center is currently conducting numerous studies to determine the effects of curcumin, an extract of turmeric root, in fighting against several types of cancers.

Dr. Bharat Aggarwal, professor of cancer research, M.D. Anderson Cancer Center stated that although there are numerous companies that supply curcumin, consumers need to be careful that they are buying the genuine product, which is why his research group recommends Curcumin C3 Complex. He also mentioned 'supercurcumin' from Sabinsa, that in addition contains BioperineÒ, a patented extract from black pepper fruits, which enhances the absorption and utilization of curcuminoids.

According to researchers at M.D. Anderson Cancer Center, curcumin blocks a key biological pathway needed for development of melanoma and other cancers. Curcumin shuts down nuclear factor-kappa B (NF-kB), a powerful master switch known to regulate expression of more than 300 genes that promote an abnormal inflammatory response that leads to a variety of disorders, including arthritis and cancer.

    HEADQUARTERS

  • Sabinsa Corporation
    20 Lake Drive
    East Windsor
    NJ 08520, USA

  • +1 732 777 1111
  • +1 732 777 1443
  • info@sabinsa.com

CERTIFICATES

Certificate Logos Certificate Logos Certificate Logos Certificate Logos

CONTACT US